Kojic Acid

1. INCI et CAS

INCI: Kojic Acid · CAS: 501-30-4

2. Rôle dans la formule

Kojic acid is restricted or under review in several markets, including EU SCCS opinions on leave-on use. This guide does not claim a whitening drug. Confirm the destination limit before any scale-up. If the market disallows it, leave it out.

3. Niveaux d'emploi typiques (repère de formulation)

• Only where the destination rule allows, often at or below 1%

Dissolve carefully. Protect from light and air. Do not assume EU leave-on acceptance.

4. Sources réglementaires et conformité mondiale

• Use CosIng's information on Kojic Acid as a reference, then verify the specific grade and intended use under market rules.
• Regulation (EC) No 1223/2009 requires an assessment of the safety of the final cosmetic containing Kojic Acid for the product in its final form.
• Use the supplier TDS to confirm grade-specific details for Kojic Acid and review the destination market's requirements.

5. Sécurité et évaluation des risques

The stated concentration is a cosmetic-development reference; the listed level does not itself confer drug or OTC status and the finished formula still needs patch and stability testing.

6. Stabilité et conditionnement

Protect sealed bulk from warmth and direct light; for oxidation-sensitive formulas, consider an airless or pump pack; check the finished batch's stability and package compatibility.

7. Formulations d'allégations (à faire / à éviter)

• Names kojic acid only as a restricted cosmetic guide

• This formulation entry does not support drug effects, cures, or certification claims that go beyond the documented ingredient information.
• The formulation record for Kojic Acid does not confirm whitening, treatment of acne, perspiration control, sun protection, or hair growth.

1. INCI et CAS

INCI: Glycerin · CAS: 56-81-5

2. Rôle dans la formule

The glycerin note covers its polyol-humectant role in washes, gels, and emulsions and gives a formulation guide level.

3. Niveaux d'emploi typiques (repère de formulation)

• For gels and serums, the recorded level is 3–8%.
• The level shown for creams is 2–5% as a formulation guide.
• Formulation guidance for rinse-off: 2–4%.

The water phase is the addition point for Glycerin; a separate melt is unnecessary.

4. Sources réglementaires et conformité mondiale

• CosIng information about Glycerin does not itself authorize a particular grade or finished cosmetic.
• Regulation (EC) No 1223/2009 requires the completed product containing Glycerin to receive its own safety assessment before the finished product is marketed.
• Confirm the received Glycerin grade against supplier documentation, then verify the intended market's filing requirements.

5. Sécurité et évaluation des risques

The use-level note is a reference for cosmetic formulation; it is not evidence of drug approval or OTC authorization and the final formula should undergo patch and stability assessment.

6. Stabilité et conditionnement

Keep bulk material sealed, cool, and out of direct sunlight; where oxidation is a concern, evaluate airless or pump packaging; confirm stability and pack fit with the final formula.

7. Formulations d'allégations (à faire / à éviter)

• The cosmetic concept for Glycerin in this entry centers on humectant function.

• This cosmetic guide provides no basis for drug claims, cure claims, or a certification that is absent from the product records.
• This guide to Glycerin does not establish skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.

1. INCI et CAS

INCI: Squalane · CAS: 111-01-3

2. Rôle dans la formule

As a hydrocarbon emollient, squalane offers stability; the grade in this guide is plant-derived rather than mineral oil.

3. Niveaux d'emploi typiques (repère de formulation)

• For gel-creams, the recorded level is 2–6% as a formulation guide.
• The level shown for dry oils is 10–30% for the formula.
• Balms: 5–15% in this reference.

Use the oil phase to introduce Squalane; a high-shear wax stage is not specified.

4. Sources réglementaires et conformité mondiale

• An entry for Squalane in CosIng is not authorization for a material grade or completed cosmetic; review local requirements.
• Regulation (EC) No 1223/2009 requires a safety assessment of the finished cosmetic containing Squalane before the finished product is marketed.
• Compare the received Squalane material with its supplier specification and review destination-market filing needs.

5. Sécurité et évaluation des risques

Read the recorded level as a cosmetic formulation guide; this reference is not approval for drug use or OTC marketing and the completed formula still requires stability and patch testing.

6. Stabilité et conditionnement

Store sealed bulk away from heat and sunlight; evaluate packaging against the formula's susceptibility to oxidation; assess the confirmed formula for stability and package compatibility.

7. Formulations d'allégations (à faire / à éviter)

• The recorded cosmetic positioning for Squalane highlights a light-emollient role.

• This ingredient reference cannot verify therapeutic outcomes, clinical cures, or a certification the finished SKU does not hold.
• The ingredient record for Squalane does not support whitening, treatment of acne, perspiration control, sun protection, or hair growth.